Macrophage Pharma
Latest round
- Series A
Last raised
- Aug 2017
Total raised
- $17M
Investors
- 4
About Macrophage Pharma
Founded in 2014 in Windsor, UK, Macrophage Pharma Limited specializes in biopharmaceutical solutions that leverage the immune system to fight cancer.52 mn. The firm has completed a total of 2 deals, with the most recent occurring on August 23, 2017.Macrophage Pharma specializes in innovative biopharmaceutical solutions targeting immune modulation and cancer therapy. Their core product offerings focus on developing therapies that harness the body's immune system to effectively combat various diseases, primarily cancer. These products are designed to enhance immune response and improve patient outcomes in complex conditions where traditional therapies may fall short. The company aims to serve a diverse clientele that includes hospitals, healthcare providers, and research institutions, with end users being patients suffering from chronic diseases and cancer.30. The company generates revenue through collaborative partnerships and direct sales to medical institutions, engaging primarily in B2B transactions. The company is focusing on launching new therapies aimed at enhancing immune responses and is specifically targeting expansions into additional European and North American markets by 2020.
Who invested in Macrophage Pharma
4 investors across 2 rounds
See all investors in Macrophage Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Macrophage Pharma
Who invested in Macrophage Pharma?
Macrophage Pharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Macrophage Pharma raised?
Macrophage Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Macrophage Pharma last raise money?
Macrophage Pharma's most recent round on record is a Series A, in Aug 2017.
What does Macrophage Pharma do?
Founded in 2014 in Windsor, UK, Macrophage Pharma Limited specializes in biopharmaceutical solutions that leverage the immune system to fight cancer.
Where is Macrophage Pharma headquartered?
Macrophage Pharma is headquartered in Windsor, UK.
Which VCs invest in companies like Macrophage Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Macrophage Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Macrophage Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.